-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SHRA-1921 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SHRA-1921 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SHRA-1921 in Solid Tumor Drug Details: SHR-A1921 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Apalutamide in Salivary Gland Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Apalutamide in Salivary Gland Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Apalutamide in Salivary Gland Cancer Drug Details: Apalutamide (Erleada, Erlyand,...
-
Sector Analysis
New Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TT-16 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TT-16 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TT-16 in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dovitinib Lactate in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dovitinib Lactate in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dovitinib Lactate in Metastatic Ovarian Cancer Drug Details: Dovitinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Endometrial Cancer Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Neuroblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Neuroblastoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Neuroblastoma Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a s-malate salt...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Hepatobiliary System Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Hepatobiliary System Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Hepatobiliary System Tumor Drug Details: Cabozantinib s-malate (Cabometyx,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Pancreatic Cancer Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a...